![Robert Cuthbertson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Cuthbertson
Directeur/Bestuurslid bij
ZENYTH THERAPEUTICS LIMITED
Vermogen: 6 M $ op 30-06-2026
Profiel
Momenteel bekleedt Andrew Cuthbertson de functie van Chief Scientific Officer & Executive Director bij CSL Ltd. en Chief Scientific Officer van CSL Behring LLC (een dochteronderneming van CSL Ltd.). Hij is tevens lid van de raad van bestuur van CSL Innovation Pty Ltd., Centre for Eye Research Australia en Grattan Institute en lid van de raad van bestuur van de Universiteit van Melbourne. Andrew Cuthbertson bekleedde voorheen de functie van Senior Scientist bij Genentech, Inc.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CSL LIMITED 0,01% | 17-02-2026 | 71.128 ( 0,01% ) | 6 M $ | 30-06-2026 |
Actieve functies van Robert Cuthbertson
| Bedrijven | Functie | Begin |
|---|---|---|
| ZENYTH THERAPEUTICS LIMITED | Directeur/Bestuurslid | - |
| CSL LIMITED | Directeur/Bestuurslid | 17-10-2018 |
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Directeur/Bestuurslid | 01-01-2018 |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01-01-2016 |
Centre for Eye Research Australia
 Centre for Eye Research Australia General GovernmentGovernment Eliminates vision loss and blindness | Directeur/Bestuurslid | 01-03-2017 |
Grattan Institute
 Grattan Institute Miscellaneous Commercial ServicesCommercial Services Develops public policy programs | Directeur/Bestuurslid | 01-01-2019 |
Eerdere bekende functies van Robert Cuthbertson
| Bedrijven | Functie | Einde |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01-01-1997 |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
67
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
CSL Innovation Pty Ltd.
 CSL Innovation Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
CSL Ltd.
 CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Institutes of Health
National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Government |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Health Technology |
Centre for Eye Research Australia
Centre for Eye Research Australia General GovernmentGovernment Eliminates vision loss and blindness | Government |
Grattan Institute
Grattan Institute Miscellaneous Commercial ServicesCommercial Services Develops public policy programs | Commercial Services |
